Q1 2026 Holdings
Filed 2026-05-15 | 12 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $225.7M | 8,713,000 | 16.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $212.9M | 2,537,191 | 15.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $211.8M | 5,503,418 | 15.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $202.7M | 4,018,101 | 14.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $181.7M | 3,705,262 | 13.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $76.6M | 3,914,458 | 5.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $72.7M | 1,855,644 | 5.3% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $64.0M | 4,553,494 | 4.6% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $50.5M | 2,747,866 | 3.6% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $46.1M | 2,359,025 | 3.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $25.1M | 298,647 | 1.8% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $14.5M | 8,625,000 | 1.0% |